gvtcx

CF CAN Advanced Wound Care

Supply Chain Coordination Limited Published 8 Jul 2025 Contracts Finder

key details

Value£1,467,008,032
Statuscomplete
Category (CPV) 33140000 +3 more
Deadline16 Oct 2024
Contract start1 Sept 2025
Contract end31 Aug 2027
Procedureopen
SME suitableYes
OCIDocds-b5fd17-78d8ef21-9955-4470-8223-4eaf575fb4e0

Awards (57)

This procurement was awarded to 57 suppliers. Values shown are per-award; the notice total is £1,467,008,032.

SupplierValueDateStatus
Absorbest AB shared £1,467,008,032 9 Apr 2025 active
Advanced Medical Solutions Ltd shared £1,467,008,032 9 Apr 2025 active
AOTI LTD shared £1,467,008,032 9 Apr 2025 active
B. Braun Medical Limited shared £1,467,008,032 9 Apr 2025 active
Becton, Dickinson U.K. Limited shared £1,467,008,032 9 Apr 2025 active
Brightwake Limited (trading as Advancis Medical) shared £1,467,008,032 9 Apr 2025 active
CD Medical Limited shared £1,467,008,032 9 Apr 2025 active
Clarity Pharma Ltd shared £1,467,008,032 9 Apr 2025 active
ClearHeal LTD shared £1,467,008,032 9 Apr 2025 active
CliniMed Ltd shared £1,467,008,032 9 Apr 2025 active
Clinisupplies Limited shared £1,467,008,032 9 Apr 2025 active
Coloplast Ltd shared £1,467,008,032 9 Apr 2025 active
ConvaTec Limited shared £1,467,008,032 9 Apr 2025 active
Creed Medical Ltd shared £1,467,008,032 9 Apr 2025 active
Crest Medical Ltd shared £1,467,008,032 9 Apr 2025 active
Dot Medical Limited shared £1,467,008,032 9 Apr 2025 active
Ennogen Healthcare Ltd shared £1,467,008,032 9 Apr 2025 active
Espère Healthcare Ltd shared £1,467,008,032 9 Apr 2025 active
Essity T/A BSN Medical Ltd shared £1,467,008,032 9 Apr 2025 active
Eurosurgical Ltd shared £1,467,008,032 9 Apr 2025 active
Firstkind Ltd shared £1,467,008,032 9 Apr 2025 active
Flen Health UK Ltd shared £1,467,008,032 9 Apr 2025 active
Frontier Therapeutics Limited shared £1,467,008,032 9 Apr 2025 active
GBUK Ltd shared £1,467,008,032 9 Apr 2025 active
Gentell UK Ltd shared £1,467,008,032 9 Apr 2025 active
Global Health and Safety Ltd. shared £1,467,008,032 9 Apr 2025 active
Griffiths and Nielsen Ltd shared £1,467,008,032 9 Apr 2025 active
GS Medical Healthcare Ltd shared £1,467,008,032 9 Apr 2025 active
Ideal Medical Solutions Ltd shared £1,467,008,032 9 Apr 2025 active
IMS Euro Ltd shared £1,467,008,032 9 Apr 2025 active
INTEGRA NEUROSCIENCES LIMITED shared £1,467,008,032 9 Apr 2025 active
Iskus Health UK Limited shared £1,467,008,032 9 Apr 2025 active
Joint Operations (UK) LLP shared £1,467,008,032 9 Apr 2025 active
KCI Medical Limited shared £1,467,008,032 9 Apr 2025 active
L&R Medical UK Ltd shared £1,467,008,032 9 Apr 2025 active
Medicareplus International Limited shared £1,467,008,032 9 Apr 2025 active
Mediq Healthcare UK Ltd shared £1,467,008,032 9 Apr 2025 active
Medi UK Ltd shared £1,467,008,032 9 Apr 2025 active
Medline Industries Ltd shared £1,467,008,032 9 Apr 2025 active
MedScience Distribution Ltd shared £1,467,008,032 9 Apr 2025 active
Molnlycke Health Care Ltd shared £1,467,008,032 9 Apr 2025 active
OscarTech UK Ltd shared £1,467,008,032 9 Apr 2025 active
Oswell Penda Pharmaceutical Ltd shared £1,467,008,032 9 Apr 2025 active
PAUL HARTMANN LIMITED shared £1,467,008,032 9 Apr 2025 active
Phoenix Medical Ltd shared £1,467,008,032 9 Apr 2025 active
Raise Healthcare Pvt Ltd shared £1,467,008,032 9 Apr 2025 active
RELIANCE MEDICAL HOLDINGS LTD shared £1,467,008,032 9 Apr 2025 active
Richardson Healthcare Ltd shared £1,467,008,032 9 Apr 2025 active
Rocialle Healthcare Ltd shared £1,467,008,032 9 Apr 2025 active
Schulke & Mayr UK Ltd shared £1,467,008,032 9 Apr 2025 active
Steroplast Healthcare Ltd shared £1,467,008,032 9 Apr 2025 active
T.J.SMITH AND NEPHEW,LIMITED shared £1,467,008,032 9 Apr 2025 active
Trion Pharma Limited shared £1,467,008,032 9 Apr 2025 active
Unisurge International Limited shared £1,467,008,032 9 Apr 2025 active
URGO LIMITED shared £1,467,008,032 9 Apr 2025 active
Vernacare International Limited shared £1,467,008,032 9 Apr 2025 active
Willingsford Limited shared £1,467,008,032 9 Apr 2025 active

description

The scope of this Framework is to cover the appropriate range of products to help influence ideal wound healing environments. The products are used to provide pathogen-free protection and/or moisten areas for healing of wounds to occur as well as prevent infection and skin breakages including, but not limited to Hydrogels, Gelling Fibres and Alginates, Wound Contact Layers, Super Absorbent Dressings, Dressing Pads, Foam Dressings, Hydrocolloid Dressings, Non-Woven Island Dressings, IV Dressings, Film and Film Island Dressings, Burns and Scar Management, Speciality Wound Care, Wound Irrigation, Debridement, Adhesive Removers, Barrier Creams and Films, Compression Bandages and Medical Adhesive Tapes.

The Framework Agreement will have an initial term of 24 months with an option to extend for up to a total period of 48 months.

It is anticipated that initial expenditure for this Framework will be circa £250,960,973 GBP in the first year of this Framework Agreement. If the Framework Agreement is extended to the maximum duration, the anticipated expenditure will be circa £1,003,843,892 GBP to £1,467,008,032 GBP.

These are approximates only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
8 Jul 2025 Award (award) · 4b76114e-5b91-421d-b54c-66150e617a9e-853323

more from Supply Chain Coordination Limited

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.